ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HIK Hikma Pharmaceuticals Plc

1,891.00
16.00 (0.85%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  16.00 0.85% 1,891.00 1,887.00 1,889.00 1,897.00 1,877.00 1,897.00 414,105 16:35:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8653 21.81 4.19B

Hikma Pharmaceuticals Plc Director Declaration

27/06/2024 1:47pm

RNS Regulatory News


RNS Number : 2000U
Hikma Pharmaceuticals Plc
27 June 2024
 

Hikma Pharmaceuticals PLC

Director Declaration

In accordance with Listing Rule 9.6.14, Hikma Pharmaceuticals PLC announces that Victoria Hull, Senior Independent Non-Executive Director, has been appointed as a Non-Executive Director of Serco Group PLC with effect from 1 September 2024.

- ENDS -

 

Enquiries:

 

Hikma Pharmaceuticals PLC

 

Helen Middlemist

Group Company Secretary

+44 20 7399 2760

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNFRMTTMTITBFI

1 Year Hikma Pharmaceuticals Chart

1 Year Hikma Pharmaceuticals Chart

1 Month Hikma Pharmaceuticals Chart

1 Month Hikma Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock